{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:16:51Z","timestamp":1791206211357,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T00:00:00Z","timestamp":1367107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00467-013-2492-x","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T02:11:57Z","timestamp":1367374317000},"page":"1315-1318","source":"Crossref","is-referenced-by-count":21,"title":["Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B"],"prefix":"10.1007","volume":"28","author":[{"given":"Rodney D.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy H.","family":"Goodship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,28]]},"reference":[{"key":"2492_CR1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fr\u00e9meaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60","journal-title":"Orphanet J Rare Dis"},{"key":"2492_CR2","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJH (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 31:E1445\u2013E1460","journal-title":"Hum Mutat"},{"key":"2492_CR3","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.molimm.2007.11.003","volume":"45","author":"F Bexborn","year":"2008","unstructured":"Bexborn F, Andersson PO, Chen H, Nilsson B, Nilsson Ekdahl K (2008) The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol 45:2370\u20132379","journal-title":"Mol Immunol"},{"key":"2492_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.mi.42.100188.001221","volume":"42","author":"KA Joiner","year":"1988","unstructured":"Joiner KA (1988) Complement evasion by bacteria and parasites. Annu Rev Microbiol 42:201\u2013230","journal-title":"Annu Rev Microbiol"},{"key":"2492_CR5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.imbio.2012.07.016","volume":"217","author":"D Ricklin","year":"2012","unstructured":"Ricklin D (2012) Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy. Immunobiology 217:1057\u20131066","journal-title":"Immunobiology"},{"key":"2492_CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","volume":"104","author":"EG Jorge de","year":"2007","unstructured":"de Jorge EG, Harris C, Esparza-Gordillo J, Carreras L, Arranz EA, Abarrategul G, L\u00f3pez-Trascasa M, S\u00e1nchez-Corral P, Morgan BP, de C\u00f3rdoba SR (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci USA 104:240\u2013245","journal-title":"Proc Natl Acad Sci USA"},{"key":"2492_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00467-012-2296-4","volume":"28","author":"N Besbas","year":"2013","unstructured":"Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F (2013) Neonatal onset hemolytic uremic syndrome successfully treated with eculizumab. Pediatr Nephrol 28:155\u2013158","journal-title":"Pediatr Nephrol"},{"key":"2492_CR8","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00467-012-2283-9","volume":"27","author":"FS Cavci","year":"2012","unstructured":"Cavci FS, Cakar N, Hancer VS, Uncu N, Acar B, Gur G (2012) Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation. Pediatr Nephrol 27:2327\u20132331","journal-title":"Pediatr Nephrol"},{"key":"2492_CR9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00467-010-1708-6","volume":"26","author":"SL Al-Akash","year":"2011","unstructured":"Al-Akash SL, Almond PS, Savill VH Jr, Gharaybey SL, Hogue C (2011) Eculizumab induces long-term remission in recurrent post transplant HUS associated with C3 gene mutation. Pediatr Nephrol 26:613\u2013619","journal-title":"Pediatr Nephrol"},{"key":"2492_CR10","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.transproceed.2010.09.125","volume":"42","author":"V Ch\u00e2telet","year":"2010","unstructured":"Ch\u00e2telet V, Lobbedez T, Fr\u00e9meaux-Bacchi V, Ficheux M, Ryckelynck JP, Hurault de Ligny B (2010) Eculizumab: safety and efficacy after 17\u00a0months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant Proc 42:4353\u20134355","journal-title":"Transplant Proc"},{"key":"2492_CR11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00277-012-1615-y","volume":"92","author":"G Salem","year":"2013","unstructured":"Salem G, Flynn J, Cataland SR (2013) Profound neurological injury in a patient with atypical hemolytic uremic syndrome. Ann Hematol 92:557\u2013558","journal-title":"Ann Hematol"},{"key":"2492_CR12","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1542\/peds.2012-0903","volume":"131","author":"M Malina","year":"2013","unstructured":"Malina M, Gulati A, Bagga A, Majid MA, Simkova E, Schaefer F (2013) Peripheral gangrene in children with atypical hemolytic uremic syndrome. Pediatrics 131:e331\u2013e335","journal-title":"Pediatrics"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2492-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2492-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2492-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:04:00Z","timestamp":1559091840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2492-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,28]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2492"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2492-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,28]]}}}